Heart Anatomy and Coronary Circulation

Coronary Artery Origin and Distribution

• The right and left main coronary arteries originate from the coronary sinuses (sinuses of Valsalva) located in the aortic root just above the aortic valve
• The left main coronary artery (LMCA) is typically short (5-10 mm) and divides into the LAD and LCx; supplies ~60-70% of left ventricular mass
• The left anterior descending (LAD) artery is the longest coronary vessel; descends in the anterior interventricular sulcus and supplies the anterior two-thirds of the interventricular septum, anterolateral left ventricle, and the apex
• The left circumflex (LCx) artery courses in the left atrioventricular groove, supplying the lateral and inferior left ventricle; gives rise to obtuse marginal branches
• The right coronary artery (RCA) typically supplies the right atrium, right ventricle, and in 80% of people, the posterior descending artery (PDA) and posterolateral branches (making this "right-dominant" distribution)

Microvasculature and Metabolic Control

• Coronary arteries are epicardial vessels; they branch into penetrating arteries that enter the myocardium and further divide into arterioles and capillaries
• Coronary autoregulation maintains constant myocardial blood flow across a range of perfusion pressures (50-140 mmHg) through metabolic and myogenic mechanisms
• Adenosine, prostaglandins, and nitric oxide (NO) are key vasodilatory metabolites released during increased metabolic demand; adenosine is the primary mediator of metabolic autoregulation
• The endothelium produces vasoactive substances—NO (vasodilator), endothelin (vasoconstrictor), and prostacyclin (vasodilator/antiplatelet)—critical for vessel tone regulation
• Collateral circulation can develop over time in chronic ischemia, potentially providing alternate perfusion routes

Coronary Blood Flow Dynamics

• Coronary flow is primarily diastolic because systolic contraction compresses intramyocardial vessels, creating resistance
• Steal phenomenon can occur with vasodilators: when a stenosis is present, dilating normal vessels may preferentially increase flow through them, paradoxically reducing flow to ischemic territories

Anatomical Variants and Anomalies

• Left dominance (~8%) or codominance (~7%) occurs when the LCx or both provide the PDA, affecting infarct patterns
• Anomalous coronary origin (e.g., RCA from left coronary sinus) can cause sudden cardiac death, especially with exercise, due to compression of the vessel between the aorta and pulmonary artery
• Myocardial bridging (vessel coursing through myocardium rather than epicardially) can cause dynamic compression during systole

Normal Coronary Anatomy—No Symptoms

• Most healthy individuals have no symptoms related to coronary circulation; normal coronary anatomy allows adequate perfusion during rest and exertion
• Clinical presentation only occurs when there is coronary stenosis (>50% narrowing typically causes hemodynamic compromise) or acute plaque rupture

Acute Coronary Syndrome (ACS)—When Coronary Disease is Symptomatic

• Angina pectoris: Chest pain or pressure that is substernal, often radiates to the left arm/jaw/back, precipitated by exertion or emotional stress, and relieved by rest or nitroglycerin (classic presentation)
• Acute myocardial infarction (MI): Severe, crushing chest pain at rest; may be associated with dyspnea, diaphoresis, nausea, and a sense of impending doom; can present atypically in elderly, diabetic, or female patients
• Acute coronary insufficiency: Crescendo angina or new-onset angina at rest indicating unstable plaque and high risk for imminent MI

Anatomically-Correlated Presentations

• LAD occlusion: Anterior wall MI; ST elevation in V1-V4; may involve anteroseptal or anterolateral regions; can cause Killip class III-IV heart failure due to large territory at risk
• RCA occlusion: Inferior wall MI (ST elevation in II, III, aVF); high risk for bradycardia and AV block due to RCA supplying the AV node in most patients
• LCx occlusion: Lateral wall MI (ST elevation in I, aVL, V5-V6); less commonly results in cardiogenic shock but can cause posterolateral infarction
• Left main coronary occlusion: Extensive territory at risk (entire left ventricle); hemodynamic collapse and cardiogenic shock; extremely high mortality

Symptom Variants

• Silent ischemia: Particularly in diabetic patients, elderly patients, or those with neuropathy; can present with MI without prodromal chest pain
• Dyspnea as anginal equivalent: Some patients (especially women and elderly) present with dyspnea, fatigue, or diaphoresis rather than chest pain

Clinical History and Risk Assessment

• Detailed characterization of chest pain (OPQRST: Onset, Provocation, Quality, Radiation, Severity, Timing) combined with cardiovascular risk factors (smoking, hypertension, diabetes, hyperlipidemia, family history)
• Framingham Risk Score or ASCVD Risk Calculator used to stratify 10-year risk and guide screening/prevention

Electrocardiography (ECG)

• 12-lead ECG is the first-line diagnostic test; records electrical activity and reveals ischemia/infarction patterns correlated to coronary territory
• ST elevation in specific leads indicates acute transmural infarction in that coronary distribution (see anatomically-correlated presentations above)
• ST depression and T-wave inversion suggest ischemia or non-ST elevation MI (NSTEMI)
• Posterior wall MI may show ST elevation in posterior leads (V7-V9) or reciprocal ST depression in V1-V3 with tall R waves
• Serial ECGs improve sensitivity for detecting dynamic changes

Cardiac Biomarkers

• Troponin I or T (cardiac-specific): Rises 2-4 hours after MI onset, peaks at 24-48 hours, remains elevated for 7-14 days; most sensitive and specific for myocardial necrosis
• Myoglobin: Rises earliest (1-2 hours) but lacks cardiac specificity; useful for early rule-out
• CK-MB: More specific than total CK for cardiac origin; useful in serial testing to assess reinfarction
• BNP/NT-proBNP: Elevated in heart failure; used to assess prognosis and guide therapy

Imaging Studies

• Stress testing (exercise or pharmacologic with adenosine/dobutamine): Inducible ST changes, anginal symptoms, or perfusion defects on imaging indicate significant coronary stenosis
• Coronary angiography (cardiac catheterization): Gold standard for coronary anatomy; directly visualizes stenoses, can measure fractional flow reserve (FFR) to assess functional significance of intermediate lesions
• Coronary CT angiography (CCTA): Noninvasive alternative for low-to-intermediate pretest probability; excellent negative predictive value for ruling out CAD

Anatomy facts that decide the answer

• Nodal blood supply: the SA nodal artery arises from the RCA in the majority of people, and the AV nodal artery arises from whichever vessel gives the PDA (the RCA in ~80%). This is why an inferior MI (II, III, aVF) produces sinus bradycardia and AV block, while an anterior MI producing block implies a large septal infarct with a worse prognosis.
• Septal split: LAD supplies the anterior two-thirds of the septum, the PDA the posterior third. A ventricular septal rupture after anterior MI is therefore an LAD complication.
• Posteromedial papillary muscle has a single blood supply from the PDA; the anterolateral papillary muscle has dual supply. So acute severe mitral regurgitation with a new holosystolic murmur and flash pulmonary edema days after an inferior MI is papillary muscle rupture — the classic tested association.
• Subendocardium is the last territory perfused and the first to become ischemic, because coronary flow is diastolic and intramyocardial pressure is highest at the inner wall; this underlies demand ischemia with tachycardia and the utility of beta blockers.
• Proximal LAD is the most common site of significant atherosclerotic stenosis; the LAD, not the left main, is the vessel called the widow-maker on exams.

Best next step / distractors

• Inferior STEMI with hypotension, clear lungs, and elevated JVP = RV infarction: give IV fluids and avoid nitrates and other preload-reducing agents. Do not choose nitroglycerin here.
• Per the 2021 ACC/AHA Chest Pain Guideline, the first test in suspected ACS is a 12-lead ECG with high-sensitivity troponin — not CCTA or stress testing, which are for stable, lower-risk presentations.
• Exertional syncope or sudden death in a young athlete should prompt thought of anomalous coronary origin with interarterial course, not simple CAD.
• Coronary steal: adenosine and dipyridamole dilate normal vessels and unmask stenoses; that is the intended mechanism of pharmacologic stress testing, not a drug error.